JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Burkitt's lymphoma
Established from the tumor mass of an African child with Burkitt lymphoma in 1967; cells express MYC mRNA
Homo sapiens Tissue:B lymphocyte Morphology:Lymphoblast; lymphoblastoid Properties: Single cells or small clusters in suspension Cytogenic data: Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
B lymphocyte Morphology:Lymphoblast; lymphoblastoid Properties: Single cells or small clusters in suspension Cytogenic data: Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Lymphoblast; lymphoblastoid Properties: Single cells or small clusters in suspension Cytogenic data: Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Single cells or small clusters in suspension Cytogenic data: Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Human hypodiploid karyotype with 4% polyploidy - 44(43-46)< 2n> X, -Y, -5, -6, +7, -10, -13, -21, +3mar, ins(1; ?)(p11; ?), ins(3)(q11q29), der(5)t(1; 5)(q25; q35), del(8)(p22), der(14)t(14; ?)(p11; ?), der(15)t(15; 21)(p11; q11) - a supernumerary ring or fragment present in 8% of cells - NAMALWA marker chromosomes present Patient: Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Female, African, 3 yrs of age Medium: RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
RPMI-1640 Medium + 10% FBS + 10 mM HEPES + 1.0 mM sodium pyruvate Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Cultures can be maintained by the addition of fresh medium or replacement of medium. Maintain at 0.5-1.5 x 10^6 cells/ml; split 1:2 to 1:3 every 2-3 days; subculture cells at 1 x 10^6 cells/ml; 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Complete culture medium supplemented with 5% (v/v) DMSO
II [ Cells Contain Herpesvirus (EBV) and Squirrel monkey retrovirus (SMRV)] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Hepatitis C: Negative DNA Profile (STR): Amelogenin: X; CSF1PO: 10, 11; D13S317: 11, 12; D16S539: 9; D5S818: 12, 13; D7S820: 11; THO1: 7, 9.3; TPOX: 6, 11; vWA: 14
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!